204 related articles for article (PubMed ID: 37768068)
1. Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression.
Hsu WH; LaBella KA; Lin Y; Xu P; Lee R; Hsieh CE; Yang L; Zhou A; Blecher JM; Wu CJ; Lin K; Shang X; Jiang S; Spring DJ; Xia Y; Chen P; Shen JP; Kopetz S; DePinho RA
Cancer Discov; 2023 Dec; 13(12):2652-2673. PubMed ID: 37768068
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Fibroblast Phenotype by Colorectal Cancer Cell-Secreted Factors Is Mostly Independent of Oncogenic KRAS.
Dias Carvalho P; Mendonça S; Martins F; Oliveira MJ; Velho S
Cells; 2022 Aug; 11(16):. PubMed ID: 36010567
[TBL] [Abstract][Full Text] [Related]
3. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
4. Association of Orai1 and Peizo1 genes expression with cellular proliferation, metastasis and angiogenesis biomarkers in colon tumor biopsies of CRC patients.
Awla F; Othman G
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):232-236. PubMed ID: 38279426
[TBL] [Abstract][Full Text] [Related]
5. One Mutation to Rule Them All: Mutant KRAS Controls Tumor Intrinsic and Microenvironment Signaling.
Müller S; Krishnamurty AT
Cancer Res; 2024 Jan; 84(1):6-8. PubMed ID: 38016110
[TBL] [Abstract][Full Text] [Related]
6. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer.
Watanabe K; Shiga K; Maeda A; Harata S; Yanagita T; Suzuki T; Ushigome H; Maeda Y; Hirokawa T; Ogawa R; Hara M; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913066
[TBL] [Abstract][Full Text] [Related]
7. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
[TBL] [Abstract][Full Text] [Related]
8. Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages.
Stadler M; Pudelko K; Biermeier A; Walterskirchen N; Gaigneaux A; Weindorfer C; Harrer N; Klett H; Hengstschläger M; Schüler J; Sommergruber W; Oehler R; Bergmann M; Letellier E; Dolznig H
Cancer Lett; 2021 Nov; 520():184-200. PubMed ID: 34256095
[TBL] [Abstract][Full Text] [Related]
9. PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.
Lai SW; Cheng YC; Kiu KT; Yen MH; Chen YW; Yadav VK; Yeh CT; Kuo KT; Chang TC
Aging (Albany NY); 2024 Jan; 16(2):1620-1639. PubMed ID: 38244581
[TBL] [Abstract][Full Text] [Related]
10. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
Kobayashi H; Gieniec KA; Lannagan TRM; Wang T; Asai N; Mizutani Y; Iida T; Ando R; Thomas EM; Sakai A; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Ng JQ; Goyne J; Radford G; Lawrence MJ; Sammour T; Hayakawa Y; Klebe S; Shin AE; Asfaha S; Bettington ML; Rieder F; Arpaia N; Danino T; Butler LM; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Takahashi M; Wang TC; Enomoto A; Woods SL; Worthley DL
Gastroenterology; 2022 Mar; 162(3):890-906. PubMed ID: 34883119
[TBL] [Abstract][Full Text] [Related]
11. Thy-1
Schliekelman MJ; Creighton CJ; Baird BN; Chen Y; Banerjee P; Bota-Rabassedas N; Ahn YH; Roybal JD; Chen F; Zhang Y; Mishra DK; Kim MP; Liu X; Mino B; Villalobos P; Rodriguez-Canales J; Behrens C; Wistuba II; Hanash SM; Kurie JM
Sci Rep; 2017 Jul; 7(1):6478. PubMed ID: 28744021
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
13. Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
Peng S; Chen D; Cai J; Yuan Z; Huang B; Li Y; Wang H; Luo Q; Kuang Y; Liang W; Liu Z; Wang Q; Cui Y; Wang H; Liu X
Mol Oncol; 2021 May; 15(5):1391-1411. PubMed ID: 33528867
[TBL] [Abstract][Full Text] [Related]
14. The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
Omoto T; Kim-Kaneyama JR; Lei XF; Orimo A; Ohnishi K; Yoshihara K; Miyauchi A; Li S; Gao L; Umemoto T; Tanaka J; Nakahara K; Takeya M; Ishida F; Kudo SE; Haraguchi S; Miyazaki T; Miyazaki A
Oncogene; 2018 Mar; 37(9):1205-1219. PubMed ID: 29242607
[TBL] [Abstract][Full Text] [Related]
15. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
[TBL] [Abstract][Full Text] [Related]
16. Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer.
Han J; Xu J; Liu Y; Liang S; LaBella KA; Chakravarti D; Spring DJ; Xia Y; DePinho RA
Genes Dev; 2023 Sep; 37(17-18):818-828. PubMed ID: 37775182
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
[TBL] [Abstract][Full Text] [Related]
18. KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.
Najumudeen AK; Fey SK; Millett LM; Ford CA; Gilroy K; Gunduz N; Ridgway RA; Anderson E; Strathdee D; Clark W; Nixon C; Morton JP; Campbell AD; Sansom OJ
Nat Commun; 2024 Jan; 15(1):100. PubMed ID: 38168062
[TBL] [Abstract][Full Text] [Related]
19. Mutant KRAS modulates colorectal cancer cells invasive response to fibroblast-secreted factors through the HGF/C-MET axis.
Dias Carvalho P; Martins F; Mendonça S; Ribeiro A; Machado AL; Carvalho J; Oliveira MJ; Velho S
Int J Cancer; 2022 Nov; 151(10):1810-1823. PubMed ID: 35869872
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity.
Peng S; Li Y; Huang M; Tang G; Xie Y; Chen D; Hu Y; Yu T; Cai J; Yuan Z; Wang H; Wang H; Luo Y; Liu X
Int J Biol Sci; 2022; 18(5):1912-1932. PubMed ID: 35342344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
